MFDS — authorised 2 August 1990
- Marketing authorisation holder: GLAXOSMITHKLINE
- Status: likely_approved
🇰🇷 L-Dipalmitoyl Lecithin in South Korea
MFDS authorised L-Dipalmitoyl Lecithin on 2 August 1990
Marketing authorisation
L-Dipalmitoyl Lecithin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is L-Dipalmitoyl Lecithin approved in South Korea?
Yes. MFDS authorised it on 2 August 1990.
Who is the marketing authorisation holder for L-Dipalmitoyl Lecithin in South Korea?
GLAXOSMITHKLINE holds the South Korean marketing authorisation.